SC 13G/A ·Filed Oct 28, 2026
Passive stake amendment
Actionable Insight • Neutral
Monitor for any future conversion to a Schedule 13D, which would signal a shift from passive to activist intent. No change in stake from prior filing suggests continued passive posture.
Latest settled: T+1d
INBX ▲ +0.49% at T+1d
NEUTRAL call +0.49% · α vs SPY +0.87% · entry $73.29 → $73.65
T+1d
+0.49%
call +0.49% · α +0.87%
$73.65
settled 10h ago
T+5d
Pending
in 6d
T+20d
Pending
in 27d
T+60d
Pending
in 3mo
Price Chart
Loading chart...
Executive Summary
Bank of America Corp filed an amended Schedule 13G disclosing a passive stake of 357,318 shares (2.4%) in Inhibrx Biosciences as of September 30, 2026. This is a routine update from a prior filing; the stake is unchanged from the previous filing.
Key Financial Metrics
Stake
2.4%
Investor
BANK OF AMERICA CORP /DE/
Key Facts
- Bank of America Corp reported beneficial ownership of 357,318 shares of Inhibrx Biosciences common stock.
- The stake represents 2.4% of outstanding shares based on 14,717,660 shares outstanding as of August 7, 2026.
- The filing is an amendment to a prior Schedule 13G; the stake amount and percentage are unchanged from the prior filing.
- Bank of America certifies the securities were acquired and held in the ordinary course of business, not for changing or influencing control.
Financial Impact
Passive stake of 2.4% valued at approximately $31.2 million based on $1.3B market cap.
ownership_percentage
Risk Factors
- No material risk identified; this is a routine passive stake amendment.
Market Snapshot
Exchange
Nasdaq
Sector
Biological Products, (No Diagnostic Substances)
Analyst Consensus
80% bullish (10 analysts)
Investment Themes
Documents Analyzed
This report is based on 3 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| SC 13G/A Filing (Primary) | 0000070858-26-000526 |
| Document: 0000070858-26-000526-index.html | 0000070858-26-000526 |
| Document: 0000070858-26-000526.txt | 0000070858-26-000526 |
19 reports for INBX
50% Hit rate @ T+60 Went positive at some point 6 of 12 best @ T+60▲ +29.54%
Filters
Rows
| Type | Now | ||||
|---|---|---|---|---|---|
Oct 28, 2026 1d ago | SC 13G/A | $73.29 | awaiting T+60 | awaiting T+60 | $73.65 (+0.49%) |
Oct 14, 2026 14d ago | Insider Buy | $90.50 | awaiting T+60 | awaiting T+60 | $73.65 (−18.62%) |
Sep 28, 2026 4w ago | Insider Cluster | $104.83 | awaiting T+60 | awaiting T+60 | $73.65 (−29.74%) |
Sep 17, 2026 6w ago | Insider Cluster | $109.35 | awaiting T+60 | awaiting T+60 | $73.65 (−32.65%) |
Sep 15, 2026 6w ago | Insider Cluster | $101.77 | awaiting T+60 | awaiting T+60 | $73.65 (−27.63%) |
Sep 15, 2026 6w ago | 144 | $101.77 | awaiting T+60 | awaiting T+60 | $73.65 (−27.63%) |
Sep 14, 2026 6w ago | 144 | $105.61 | awaiting T+60 | awaiting T+60 | $73.65 (−30.26%) |
Sep 11, 2026 6w ago | 144 | $109.27 | awaiting T+60 | awaiting T+60 | $73.65 (−32.60%) |
Sep 10, 2026 6w ago | Insider Cluster | $109.27 | awaiting T+60 | awaiting T+60 | $73.65 (−32.60%) |
Sep 8, 2026 7w ago | Insider Cluster | $112.86 | awaiting T+60 | awaiting T+60 | $73.65 (−34.74%) |
Showing 10 of 19
US Market Status
Market Closed · Opens Fri (15h 41m)
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers